The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD Patients

Study Summary

The study was conducted to assess safety and immunogenicity of recombinant human erythropoietin (rhEPO) manufactured by Daewoong Pharmaceutical Co., Ltd was similar to biological products approved by the drug safety regulatory authority.